JPS57146798A - Hexosyl nucleoside derivative - Google Patents
Hexosyl nucleoside derivativeInfo
- Publication number
- JPS57146798A JPS57146798A JP56032729A JP3272981A JPS57146798A JP S57146798 A JPS57146798 A JP S57146798A JP 56032729 A JP56032729 A JP 56032729A JP 3272981 A JP3272981 A JP 3272981A JP S57146798 A JPS57146798 A JP S57146798A
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- group
- cho
- hexosyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
NEW MATERIAL:The hexosyl nucleoside derivative of formulaI(B is nucleic acid base; R1 is H, provided that when R2 is H, then R1 is NO2, NH2, CHO or CH2OH; R2 is H, provided that when R1 is H, R2 is CHO or CH2OH; when R1 is NO2 or NH2, then R3 is group of formula II, and when R1 or R2 is CHO or CH2OH, R3 is group of formula III), and its protected compound.
EXAMPLE: 2',3'-Dideoxy-3'-(S)-hydroxymethyluridine.
USE: 2'-Deoxynucleoside antagonist (nucleic acid metabolism inhibiting agent, enzymatic reaction inhibiting agent, antitumor agent, antiviral agent, etc.).
PROCESS: For example, the 4- and 6-positions of 3'-deoxy-3'-nitro-β-D-glucopyranosyluracil are protected with benzaldehyde, and the protecting groups are removed after converting the compound to 2,3-dideoxy derivative. The nitro group of the product is reduced to amino group, and diazotized. The product is converted to 3'-formyl derivative and then intramolecular hemiacetal derivative, and reduced with NaBH4 to obtain the exemplified compound.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56032729A JPS57146798A (en) | 1981-03-06 | 1981-03-06 | Hexosyl nucleoside derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56032729A JPS57146798A (en) | 1981-03-06 | 1981-03-06 | Hexosyl nucleoside derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS57146798A true JPS57146798A (en) | 1982-09-10 |
Family
ID=12366924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56032729A Pending JPS57146798A (en) | 1981-03-06 | 1981-03-06 | Hexosyl nucleoside derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57146798A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5145960A (en) * | 1989-04-24 | 1992-09-08 | E. R. Squibb & Sons, Inc. | Pyrimidinyl tetrahydrofurans |
US5164520A (en) * | 1989-04-24 | 1992-11-17 | E. R. Squibb & Sons, Inc. | Intermediates for purinyl and pyrimidinyl tetrahydrofurans |
US5215970A (en) * | 1987-04-16 | 1993-06-01 | Medivir Ab | Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds |
US5272152A (en) * | 1990-07-02 | 1993-12-21 | E. R. Squibb & Sons, Inc. | Purinyl and pyrimidinyl tetrahydrofurans |
US5473063A (en) * | 1990-10-02 | 1995-12-05 | Medivir Ab | Synthesis of furanosyl compounds useful as intermediates in preparation of nucleoside analogues |
US6576763B1 (en) | 1996-02-16 | 2003-06-10 | Medivir Ab | Acyclic nucleoside derivatives |
-
1981
- 1981-03-06 JP JP56032729A patent/JPS57146798A/en active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5215970A (en) * | 1987-04-16 | 1993-06-01 | Medivir Ab | Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds |
US5409906A (en) * | 1987-04-16 | 1995-04-25 | Medivir Ab | α nucleoside compounds and a method for treating HBV using said compounds |
US5145960A (en) * | 1989-04-24 | 1992-09-08 | E. R. Squibb & Sons, Inc. | Pyrimidinyl tetrahydrofurans |
US5164520A (en) * | 1989-04-24 | 1992-11-17 | E. R. Squibb & Sons, Inc. | Intermediates for purinyl and pyrimidinyl tetrahydrofurans |
US5272152A (en) * | 1990-07-02 | 1993-12-21 | E. R. Squibb & Sons, Inc. | Purinyl and pyrimidinyl tetrahydrofurans |
US5473063A (en) * | 1990-10-02 | 1995-12-05 | Medivir Ab | Synthesis of furanosyl compounds useful as intermediates in preparation of nucleoside analogues |
US5747473A (en) * | 1990-10-02 | 1998-05-05 | Medivir Ab | L-nucleoside analogues and pharmaceutical compositions |
US5952500A (en) * | 1990-10-02 | 1999-09-14 | Medivir Ab | Nucleoside derivatives |
US6121431A (en) * | 1990-10-02 | 2000-09-19 | Medivir Ab | Nucleoside derivatives |
US6576763B1 (en) | 1996-02-16 | 2003-06-10 | Medivir Ab | Acyclic nucleoside derivatives |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5791997A (en) | 5'-o-acylnucleoside and its preparation | |
JPS57146798A (en) | Hexosyl nucleoside derivative | |
DE3568783D1 (en) | New 8-substituted nucleoside and purine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them | |
JPS57165387A (en) | Prparation of fluoran derivative | |
EP0277599A3 (en) | Fluorine containing cyclopentane derivatives and processes for their production | |
JPS5731696A (en) | Anthracycline derivative | |
JPS535180A (en) | Preparation of 3,4-dihydro-2 (1h) quinazoline derivatives | |
JPS54151987A (en) | Preparation of 3',5'-disubstituted-2'-deoxy-beta-uridines and 2'-deoxy-beta-urdines | |
JPS57114516A (en) | Inhibitor of phosphodiesterase reaction | |
JPS5762278A (en) | Theobromine derivative and its preparation | |
JPS5634697A (en) | Preparation of 5'-triphosphoryladnylyl-(2'-5')-adenylyl-(2'-5')-adenosine | |
JPS5323916A (en) | Preparation of thioglycosides | |
JPS57106696A (en) | 1-(beta-d-arabinofuranosyl)cytosine derivative and its preparation | |
JPS57128700A (en) | P1-guanosine-5', p4-adenosine-5'-tetraphosphate | |
JPS5239699A (en) | Improved methods of producing adenosine derivatives | |
JPS5721400A (en) | Novel fortimicin derivative | |
JPS57171989A (en) | Aminometyl-secalonic acid and its preparation | |
JPS52125108A (en) | Synthesis of 1,1,1-trimethoxyethane | |
JPS56142296A (en) | Adenosine derivative and its preparation | |
JPS5731649A (en) | Preparation of hydrazone derivative | |
JPS5610150A (en) | Preparation of nitrotoluene derivative | |
JPS5632497A (en) | N6-omega-aminoalkyladenosine-3'-monophosphate | |
JPS5233683A (en) | Preparation of 1-(2'-tetrahydrofuryl)-5-flurouracil | |
JPS574981A (en) | Novel amino glucoside | |
JPS56122337A (en) | Erythro-3-fluoro-3- substituted or unsubstituted phenylalanine compound, and its preparation |